Study to Access Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Compound S0597 by Oral Inhalation: A Phase I/IIa Observer and Double Blind, Placebo and Active Controlled Parallel and Crossover Study.

Trial Profile

Study to Access Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Compound S0597 by Oral Inhalation: A Phase I/IIa Observer and Double Blind, Placebo and Active Controlled Parallel and Crossover Study.

Completed
Phase of Trial: Phase I/II

Latest Information Update: 07 Apr 2016

At a glance

  • Drugs SUN 0597 (Primary)
  • Indications Asthma
  • Focus Adverse reactions
  • Sponsors Sun Pharma Advanced Research Company
  • Most Recent Events

    • 30 Mar 2016 No of arms changed from 3 to 6 as per ClinicalTrials.gov record.
    • 30 Mar 2016 Status changed from not yet recruiting to completed as per ClinicalTrials.gov record.
    • 25 Feb 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top